JTC Employer Solutions Trustee’s iShares Biotechnology ETF IBB Stock Holding History

JTC Employer Solutions Trustee’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,107	Closed	-$141K	–	314
2025 Q1	$141K	Hold	1,107	–	–	0.01%	164
2024 Q4	$146K	Sell	1,107 -1,107	-50%	-$156K	0.01%	162
2024 Q3	$322K	Sell	2,214 -695	-24%	-$101K	0.02%	100
2024 Q2	$399K	Hold	2,909	–	–	0.03%	86
2024 Q1	$401K	Buy	2,909 +695	+31%	+$94.9K	0.03%	91
2023 Q4	$303K	Sell	2,214 -2,600	-54%	-$317K	0.03%	100
2023 Q3	$589K	Hold	4,814	–	–	0.05%	72
2023 Q2	$611K	Hold	4,814	–	–	0.06%	71
2023 Q1	$622K	Hold	4,814	–	–	0.07%	71
2022 Q4	$633K	Hold	4,814	–	–	0.05%	71
2022 Q3	$563K	Hold	4,814	–	–	0.09%	62
2022 Q2	$567K	Hold	4,814	–	–	0.07%	57
2022 Q1	$626K	Hold	4,814	–	–	0.07%	61
2021 Q4	$735K	Hold	4,814	–	–	0.09%	60
2021 Q3	$778K	Hold	4,814	–	–	0.1%	54
2021 Q2	$788K	Buy	+4,814	New	+$742K	0.12%	40

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

JTC Employer Solutions Trustee's IBB Position: Q2 2025 in Review

JTC Employer Solutions Trustee sold out of iShares Biotechnology ETF (IBB) in Q2 2025, closing a stake of 1,107 shares — an estimated $141K sold.

JTC Employer Solutions Trustee first reported a position in IBB in Q2 2021 and held it in 16 quarters. The position peaked at $788K in Q2 2021. 797 funds tracked by Wall St. Rank hold IBB as of Q2 2025.

JTC Employer Solutions Trustee reported no remaining iShares Biotechnology ETF position as of Q2 2025 after selling out during the quarter.
JTC Employer Solutions Trustee sold 1,107 iShares Biotechnology ETF shares in Q2 2025, an estimated $141K.
JTC Employer Solutions Trustee first reported a position in iShares Biotechnology ETF in Q2 2021 and held it in 16 quarters.
JTC Employer Solutions Trustee's iShares Biotechnology ETF position peaked at $788K in Q2 2021.
797 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2025.

Based on JTC Employer Solutions Trustee's 13F filing for Q2 2025, filed 29 Jul 2025.